Psilocybin-induced mystical experiences linked to lasting positive psychological effects
Psilocybin, the psychoactive compound in magic mushrooms, has been shown to be an promising treatment of mood and addictive disorders....
New studies shed light on the mysterious process by which psilocybin can rapidly improve depression symptoms
Despite a number of clinical trials showing that psilocybin can rapidly treat depression, including for cancer-related anxiety and depression, little...
Cannabis users expect cannabis-assisted therapy for depression to work as well as psilocybin-assisted therapy
Psilocybin-assisted therapy has shown promise as a treatment for depression. New research published in Cannabis finds that cannabis users expected...
Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-lived
An analysis of a large international drug survey suggests that psilocybin is a relatively safe drug, with only 0.2% of...
People who hear about psilocybin-assisted therapy think it’s important to have a guide who has used psilocybin
People with depressive symptoms appear to think it is relatively important that guides for psilocybin-assisted psychotherapy have personally used the...
Psilocybin use was associated with lowered odds of opioid use disorder
Opioid abuse is a prevalent and very dangerous substance use disorder. Psychedelic use has been proposed as a treatment for...
How credible is psilocybin-assisted therapy? Study suggests people are cautious about psychedelic treatment for depression
Psilocybin is the primary mind-altering substance in psychedelic “magic” mushrooms. Preliminary research has indicated that combining psilocybin with supportive psychotherapy...
New research sheds light on how psilocybin influences sleeping patterns
The psychedelic substance psilocybin causes transient changes to the sleep-wake architecture of laboratory mice, according to new preliminary research published...
Psilocybin use associated with lowered odds of having been arrested, study finds
The use of psilocybin -- the active component of "magic" mushrooms -- is associated with a decreased likelihood of engaging...
Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study
Consuming small doses of psilocybin at regular intervals -- a process known as microdosing -- does not appear to improve...
Psilocybin-assisted psychotherapy reduces loss of meaning and suicidal ideation among cancer patients
Recent findings published in the journal ACS Pharmacology & Translational Science suggest that psilocybin, in conjunction with psychotherapy, reduces suicidal ideation and...
Psilocybin therapy boosts cognitive and neural flexibility in depressed patients, study finds
Psilocybin-assisted psychotherapy appears to increase both cognitive and neural flexibility in patients with major depressive disorder, according to new research...
Psilocybin-assisted psychotherapy might help to reduce attachment anxiety
Scientists have begun to examine whether the psychedelic drug psilocybin, the active component of "magic" mushrooms, can help people who...
Most mental health patients support further research into the therapeutic potential of psilocybin, study finds
People who use mental health services in Ireland generally have a favorable view of psychedelic research, according to a new...
Psilocybin appears to alter how the brain integrates tactile sensory inputs
A new double-blind, placebo-controlled neuroimaging study sheds light on how psilocybin alters the way in which the brain processes tactile...
